Kevin Coleman
About
In The Last Decade
Kevin Coleman
40 papers receiving 4.7k citations
Hit Papers
Peers
Comparison fields: 5 of 128
- Molecular Biology 4.1k
- Oncology 926
- Hematology 669
- Genetics 476
- Cellular and Molecular Neuroscience 382
Countries citing papers authored by Kevin Coleman
This map shows the geographic impact of Kevin Coleman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin Coleman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin Coleman more than expected).
Fields of papers citing papers by Kevin Coleman
This network shows the impact of papers produced by Kevin Coleman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin Coleman. The network helps show where Kevin Coleman may publish in the future.
Co-authorship network of co-authors of Kevin Coleman
This figure shows the co-authorship network connecting the top 25 collaborators of Kevin Coleman. A scholar is included among the top collaborators of Kevin Coleman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin Coleman. Kevin Coleman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Title | Journal | Authors | Indexed citations |
|---|---|---|---|---|
| 1 | PARP inhibitor synthetic lethality in ATM biallelic mutant cancer cell lines is associated with BRCA1/2 and RAD51 downregulation | Frontiers in Oncology | Kevin Coleman et al. | 4 |
| 2 | Elucidation of PARP inhibitor activity in BRCAwt recurrent ovarian cancer by hrr mutational gene profile analysis. | Journal of Clinical Oncology | Mansoor Raza Mirza, Bin Feng et al. | 2 |
| 3 | BET protein proteolysis targeting chimera (PROTAC) exerts potent lethal activity against mantle cell lymphoma cells | Leukemia | Baohua Sun, Warren Fiskus et al. | 136 |
| 4 | Proteolysis-Targeting Chimeras: Harnessing the Ubiquitin-Proteasome System to Induce Degradation of Specific Target Proteins | Kevin Coleman, Craig M. Crews | 52 | |
| 5 | PROTAC BET degraders are more broadly effective than BET inhibitors | European Journal of Cancer | Julia Winkler, Kanak Raina et al. | 3 |
| 6 | PROTAC-induced BET protein degradation as a therapy for castration-resistant prostate cancer breakdown → | Proceedings of the National Academy of Sciences | Kanak Raina, Jing Lü et al. | 661 |
| 7 | Hijacking the E3 Ubiquitin Ligase Cereblon to Efficiently Target BRD4 breakdown → | Chemistry & Biology | Jing Lü, Yimin Qian et al. | 849 |
| 8 | Discovery and Pharmacologic Characterization of CP-724,714, a Selective ErbB2 Tyrosine Kinase Inhibitor | Cancer Research | Jitesh P. Jani, Richard S. Finn et al. | 62 |
| 9 | Phosphorylation of serine residues in histidine-tag sequences attached to recombinant protein kinases: A cause of heterogeneity in mass and complications in function | Protein Expression and Purification | Ping Du, Chun Luo et al. | 20 |
| 10 | Severe diabetes, age-dependent loss of adipose tissue, and mild growth deficiency in mice lacking Akt2/PKBβ breakdown → | Journal of Clinical Investigation | Robert S. Garofalo, Stephen Orena et al. | 594 |
| 11 | Dwarfism, impaired skin development, skeletal muscle atrophy, delayed bone development, and impeded adipogenesis in mice lacking Akt1 and Akt2 breakdown → | Genes & Development | Xiao-ding Peng, Mei-Ling Chen et al. | 693 |
| 12 | The EGF/TGFα response element within the TGFα promoter consists of a multi-complex regulatory element | Oncogene | Rana Awwad, Lisa E. Humphrey et al. | 7 |
| 13 | Regulation of Transforming Growth Factor α Expression in a Growth Factor-Independent Cell Line | Molecular and Cellular Biology | Gillian Howell, Lisa E. Humphrey et al. | 16 |
| 14 | Aberrant Regulation of Transforming Growth Factor-α during the Establishment of Growth Arrest and Quiescence of Growth Factor Independent Cells | Journal of Biological Chemistry | Gillian Howell, Lisa E. Humphrey et al. | 17 |
| 15 | Identification of CDK4 Sequences Involved in Cyclin D1 and p16 Binding | Journal of Biological Chemistry | Kevin Coleman, Barri Wautlet et al. | 79 |
| 16 | Autocrine Transforming Growth Factor-β1 and β2 Expression Is Increased by Cell Crowding and Quiescence in Colon Carcinoma Cells | Experimental Cell Research | Lu‐Zhe Sun, Shaoping Wu et al. | 25 |
| 17 | Expert systems development standards | Expert Systems with Applications | D. J. Gorney, Kevin Coleman | 1 |
| 18 | Expression of engrailed proteins in arthropods, annelids, and chordates breakdown → | Cell | Nipam H. Patel, Enrique Martı́n-Blanco et al. | 903 |
| 19 | The invected gene of Drosophila: sequence analysis and expression studies reveal a close kinship to the engrailed gene. | Genes & Development | Kevin Coleman, Stephen J. Poole et al. | 142 |
| 20 | Molecular Cloning of Chromosome I DNA from Saccharomyces cerevisiae: Isolation and Characterization of the CDC24 Gene and Adjacent Regions of the Chromosome | Molecular and Cellular Biology | Kevin Coleman, H. Yde Steensma et al. | 19 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.